Zevalin
Nordic MCL-3 study: BEAM/C conditioning intensified with 90Y-Ibritumomab-Tiuxetan in responding non-CR patients followed by autologous transplant in mantle cell lymphoma.(Blood 2014;123:2953-2959)本研究の主な目的は、移植前にCRを達成出来な…
Nordic MCL-3 study: BEAM/C conditioning intensified with 90Y-Ibritumomab-Tiuxetan in responding non-CR patients followed by autologous transplant in mantle cell lymphoma.(Blood 2014;123:2953-2959)本研究の主な目的は、移植前にCRを達成出来な…